Immunohistochemical staining revealed that ACSS2 expression was significantly greater in normal tissues than in hepatocellular carcinoma and metastatic liver cancer (Fig. 1a, b), indicating that the ACSS2 expression is lower in malignant tumors than in normal tissues. This evidence concerns the gene ACSS2 and hepatocellular carcinoma.